 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 5 | 1/1 | 返回列表 |
| 查看: 4097 | 回復(fù): 12 | ||||
| 當(dāng)前只顯示滿足指定條件的回帖，點擊這里查看本話題的所有回帖 | ||||
[交流]
[求助]如何處理這樣的審稿意見：The study is descriptive in nature 已有8人參與
|
||||
2月底投了一篇文章到JBC，審稿很快，半個月就給出審稿結(jié)果了，可是令人很糾結(jié)，編輯并沒有拒掉，而是希望改后重投（declined and resubmitted）。我仔細看了兩個審稿人的意見，第二個審稿人的意見比較具體，而且大多是寫作方面的，還比較能夠針對性地修改；但第一個審稿人就只有一句話The study while interesting is descriptive in nature.讓人很是抓狂 。由于編輯已告知再投時需要在cover letter中詳細說明針對審稿人提出的意見的修改情況，現(xiàn)在不知道該如何對這樣的審稿意見做出回復(fù)，懇請高人給出意見。下面附上審稿信原文： Your manuscript has been reviewed by the Editorial Board. Unfortunately, the decision was made to decline the manuscript in its current form. One reviewer indicates that the study is too descriptive and the other finds numerous items that need attention. If you can address the issues raised, I would be willing to consider a revised paper. Note that no guarantee of acceptance of the revised manuscript is implied. Reviewer 1 COMMENTS FOR THE AUTHOR: The study while interesting is descriptive in nature. Reviewer 2 COMMENTS FOR THE AUTHOR: Manuscript No: JBC/2012/356428 Comments to the authors: The manuscript reports that YCP selectively promotes the activation of B cells through Toll-like receptor 2 and Toll-like receptor 4. The authors presented experimental evidence to show that YCP binds to TLR2 and TLR4 of B cell, activates a serial events of signaling pathways including p38, ERK, JNK, and NF-κB , which eventually leads to the activation of B cell as indicated by proliferation and IgM production. The experiments are designed reasonable and well down, the findings are significant. The manuscript needs revision: 1. It seems to me that the “EXPERIMENTAL PROCEDURES” part is too wordy. 2. I recommend authors to re-write the ELISA-paragraph. 3. In the figure 2-A, each panel should also includes the same field panel with normal light observation to show all the cells in the field. 4. Let the editor to decide if the figure 6 is necessary, or in other words, if there is enough information to construct the signaling pathway? 5. English language should be checked carefully for accurate and unambiguous expressions. |
回復(fù)此樓» 收錄本帖的淘帖專輯推薦
 SCI寫作、投稿、經(jīng)驗 |
» 猜你喜歡
287求調(diào)劑
已經(jīng)有7人回復(fù)
-
325求調(diào)劑
已經(jīng)有5人回復(fù)
-
343求調(diào)劑
已經(jīng)有4人回復(fù)
-
求調(diào)劑推薦 材料 304
已經(jīng)有4人回復(fù)
-
316求調(diào)劑
已經(jīng)有4人回復(fù)
-
351求調(diào)劑
已經(jīng)有4人回復(fù)
-
349求調(diào)劑
已經(jīng)有5人回復(fù)
-
材料學(xué)碩333求調(diào)劑
已經(jīng)有7人回復(fù)
-
342求調(diào)劑
已經(jīng)有3人回復(fù)
-
調(diào)劑求收留
已經(jīng)有7人回復(fù)
» 本主題相關(guān)價值貼推薦，對您同樣有幫助:
- The tube was incubated 怎么翻譯呢？
已經(jīng)有3人回復(fù)
- 分享今日最新Nature文章：10nm以下金屬納米顆粒的等離子共振研究
已經(jīng)有371人回復(fù)
- 哪位愿做Spectrochimica Acta 的審稿人
已經(jīng)有13人回復(fù)
- 如何回答審稿人問題
已經(jīng)有4人回復(fù)
- 這個審稿意見如何回答（HOMO能級計算方面）？
已經(jīng)有29人回復(fù)
- 投稿時要寫一個不受歡迎的審稿人，這可咋寫啊？
已經(jīng)有32人回復(fù)
- 審稿一篇4.0的論文，作者感謝了8個基金。不厚道，真想斃了。
已經(jīng)有23人回復(fù)
- RSC和ACS的審稿意見結(jié)果什么的是共享的嗎？？被拒后重投有什么經(jīng)驗？？
已經(jīng)有10人回復(fù)
- 審稿意見回復(fù)了，大家?guī)兔纯催@個該如何處理才更好
已經(jīng)有3人回復(fù)
- 求助對JCED審稿意見的理解
已經(jīng)有7人回復(fù)
- 求助 誰有審稿的經(jīng)驗？給些建議哈
已經(jīng)有14人回復(fù)
- 最近審稿人都休息嗎？
已經(jīng)有7人回復(fù)
- 給推薦的審稿人寫信，可以嗎？
已經(jīng)有14人回復(fù)
- 審稿意見：英文摘要需要重新改寫，可以詳細些，注意介詞用法~求幫個小忙�。�！
已經(jīng)有2人回復(fù)
- 編輯發(fā)錯審稿意見，但文章無進展，如何處理
已經(jīng)有9人回復(fù)
4樓2012-03-14 16:13:47
Luckyman2012
木蟲 (知名作家)
- 應(yīng)助: 392 (碩士)
- 貴賓: 2.047
- 金幣: 2374.2
- 散金: 14033
- 紅花: 49
- 沙發(fā): 106
- 帖子: 9318
- 在線: 512.3小時
- 蟲號: 1606693
- 注冊: 2012-02-08
- 性別: GG
- 專業(yè): 礦物工程與物質(zhì)分離科學(xué)
2樓2012-03-14 15:43:44
3樓2012-03-14 16:00:21
山東老杜
木蟲 (正式寫手)
- 應(yīng)助: 12 (小學(xué)生)
- 金幣: 2546.6
- 散金: 2308
- 紅花: 6
- 帖子: 395
- 在線: 259.1小時
- 蟲號: 1088911
- 注冊: 2010-09-04
- 專業(yè): 腫瘤免疫
5樓2012-03-14 16:29:46
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 342求調(diào)劑 +3 | 加油a李zs 2026-03-26 | 3/150 |
|
|---|---|---|---|---|
|
|
[考研] 305求調(diào)劑 +4 | 哇盧卡庫 2026-03-26 | 4/200 |
|
|
|
[考研] 321求調(diào)劑 +6 | Ymlll 2026-03-24 | 6/300 |
|
|
[考研] 【雙一流院校新能源、環(huán)境材料，材料加工與模擬招收大量調(diào)劑】 +4 | Higraduate 2026-03-22 | 8/400 |
|
|
|
[考研] 085701環(huán)境工程，267求調(diào)劑 +4 | minht 2026-03-26 | 4/200 |
|
|
|
[考研]
 材料與化工考研調(diào)劑
+10
|
孅華 2026-03-22 | 10/500 |
|
|
|
[考研] 308求調(diào)劑 +5 | 墨墨漠 2026-03-25 | 5/250 |
|
|
|
[考研] 284求調(diào)劑 +15 | Zhao anqi 2026-03-22 | 15/750 |
|
|
|
[考研] 材料調(diào)劑 +3 | iwinso 2026-03-23 | 3/150 |
|
|
|
[考研] 一志愿吉林大學(xué)材料與化工303分求調(diào)劑 +4 | 為學(xué)666 2026-03-24 | 4/200 |
|
|
|
[考研] 考研化學(xué)308分求調(diào)劑 +10 | 你好明天你好 2026-03-23 | 11/550 |
|
|
|
[考研] 0703化學(xué)調(diào)劑，求導(dǎo)師收 +7 | 天天好運來上岸?/a> 2026-03-24 | 7/350 |
|
|
|
[有機交流]
有機合成求助
 20+3
|
FENGSHUJEI 2026-03-23 | 5/250 |
|
|
|
[考研] 求調(diào)劑 +5 | 林之夕 2026-03-24 | 5/250 |
|
|
|
[基金申請] 請教下大家 2026年國家基金申請是雙盲審嗎？ +3 | lishucheng1 2026-03-22 | 5/250 |
|
|
|
[考研] 一志愿山東大學(xué)藥學(xué)學(xué)碩求調(diào)劑 +3 | 開開心心沒煩惱 2026-03-23 | 4/200 |
|
|
|
[考研] 材料/農(nóng)業(yè)專業(yè)，07/08開頭均可，過線就行 +3 | 呵唔哦豁 2026-03-23 | 4/200 |
|
|
|
[考研] 384求調(diào)劑 +3 | 子系博 2026-03-22 | 6/300 |
|
|
|
[考研] 275求調(diào)劑 +6 | shansx 2026-03-22 | 8/400 |
|
|
|
[考研] 考研調(diào)劑 +3 | 呼呼？~+123456 2026-03-21 | 3/150 |
|